Related Experiment Video
Updated: Jun 2, 2026

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
Vaccination of children and adolescents with rheumatic diseases
Laura Dell' Era1, Susanna Esposito, Fabrizia Corona
1Department of Maternal and Pediatric Sciences, Università degli Studi di Milano, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Commenda 9, 20122 Milano, Italy.
Insights
Children with rheumatic diseases (RDs) benefit from standard vaccination schedules. Pneumococcal and influenza vaccines are strongly recommended to prevent severe infections in these vulnerable patients.
Area of Science:
- Pediatric Rheumatology
- Immunology
- Vaccinology
Background:
- Children with rheumatic diseases (RDs) have compromised immunity and often use immunosuppressive drugs.
- Vaccination in RDs is debated due to concerns about insufficient immune response and potential autoimmune triggers.
Purpose of the Study:
- To review available data on vaccine risks, immunogenicity, efficacy, and tolerability in children with RDs.
- To provide evidence-based recommendations for vaccination in this population.
Main Methods:
- Systematic review of existing literature on vaccines in pediatric rheumatic diseases.
- Analysis of data on immune response, protection, and adverse events following vaccination.
Main Results:
- Vaccination is generally safe and recommended for children with RDs, following standard schedules.
- Pneumococcal and influenza vaccinations are particularly crucial due to high infection risks in RD patients.
- Current data indicate sufficient immunogenicity and tolerability for recommended vaccines.
Conclusions:
- Children with RDs should adhere to recommended vaccination schedules.
- Enhanced emphasis on pneumococcal and influenza vaccines is warranted for infection prevention.
- Further research is needed to address specific knowledge gaps in RD vaccination.
Abstract:
Children with rheumatic diseases (RDs) are at greater risk of infection because of their aberrant immunity and frequent use of immunosuppressive drugs. However, the use of vaccinations in such children is debated by many experts who think that the patients' immune response is insufficient to assure protection; some of them are also afraid that vaccines could trigger a persistent autoimmune response and lead to severe clinical problems including a relapse of the RD. This review describes the available data regarding the risks of vaccine administration, and the immunogenicity, efficacy and tolerability of the vaccines usually recommended for children with RDs. The data not only show that the schedule suggested for otherwise healthy children should be followed, but also that pneumococcal and influenza vaccinations should be strongly recommended because of the known risk of severe infections in patients with RD. However, there are areas in which further research is urgently required.
Related Concept Videos
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease IV: Nursing Management
Respiratory Syncytial Virus Disease
Vaccinations
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
